Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; sodium lauryl sulfate; purified water; pregelatinised maize starch; titanium dioxide; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; titanium dioxide; gelatin; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 250 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 10 milligram(s) - other antipsychotics; aripiprazole

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 15 milligram(s) - other antipsychotics; aripiprazole

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 30 milligram(s) - other antipsychotics; aripiprazole

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 5 milligram(s) - other antipsychotics; aripiprazole

Euroopa Liit - inglise - EMA (European Medicines Agency)

accord healthcare s.l.u. - pregabalin - anxiety disorders; epilepsy - antiepileptics, - epilepsypregabalin accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.generalised anxiety disorderpregabalin accord is indicated for the treatment of generalised anxiety disorder (gad) in adults.